Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX)

CUSIP: 00972G207

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Ordinary Shares, $0.000000005 par value
Shares outstanding
94,284,567,045
Total 13F shares
123,042
Share change
+123,042
Total reported value
$486,015
Price per share
$3.95
Number of holders
7
Value change
+$486,015
Number of buys
7

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 00972G207?
CUSIP 00972G207 identifies AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SABBY MANAGEMENT, LLC
13F
Company
class O/S missing
7,392,131
$1,256,662 30 Jun 2023
13F
Omnia Family Wealth, LLC
13F
Company
class O/S missing
782,372
$133,003 30 Jun 2023
13F
NEA Management Company, LLC
13F
Company
class O/S missing
452,167
$76,868 30 Jun 2023
13F
Cerity Partners LLC
13F
Company
class O/S missing
322,862
$54,887 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
318,250
$54,000 30 Jun 2023
13F
Cresset Asset Management, LLC
13F
Company
class O/S missing
216,666
$36,833 30 Jun 2023
13F
LPL Financial LLC
13F
Company
class O/S missing
134,453
$22,857 30 Jun 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
class O/S missing
134,046
$22,774 30 Jun 2023
13F
Hikari Power Ltd
13F
Company
class O/S missing
130,821
$22,000 30 Jun 2023
13F
Bryn Mawr Trust Advisors, LLC
13F
Company
class O/S missing
100,000
$17,000 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
30,264
$5,141 30 Jun 2023
13F
UBS Group AG
13F
Company
class O/S missing
24,463
$4,159 30 Jun 2023
13F
Virtu Financial LLC
13F
Company
class O/S missing
16,437
$3,000 30 Jun 2023
13F
TWO SIGMA SECURITIES, LLC
13F
Company
class O/S missing
17,613
$2,994 30 Jun 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
3,000
$510 30 Jun 2023
13F
Truvestments Capital LLC
13F
Company
class O/S missing
1,005
$171 30 Jun 2023
13F

Institutional Holders of Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) as of Q3 2023

As of 30 Sep 2023, Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 123,042 shares. The largest 7 holders included Omnia Family Wealth, LLC, Cerity Partners LLC, NEA Management Company, LLC, RENAISSANCE TECHNOLOGIES LLC, BANK OF AMERICA CORP /DE/, Truvestments Capital LLC, and Cornerstone Planning Group LLC. This page lists 7 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q4 2025 Across Filers

Q4 2025 holders
21
Q3 2023 holders
7
Holder diff
-14
Investor Q4 2025 Shares Q3 2023 Shares Share Diff Share Chg % Q4 2025 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.